---
url: "https://www.lek.com/leadership/christopher-stern"
title: "Christopher Stern | L.E.K. Consulting"
---

[Skip to main content](https://www.lek.com/leadership/christopher-stern#main-content)

[![L.E.K.](https://www.lek.com/themes/lek/images/new-logo.svg)](https://www.lek.com/ "L.E.K.")

Search

- English
- List additional actions
- [Português](https://www.lek.com/pt-br/lek-brazil)
- [简体中文](https://www.lek.com/zh-hant/lek-china)
- [Deutsch](https://www.lek.com/de/lek-germany)
- [日本語](https://www.lek.com/ja/lek-japan)

# Christopher Stern

Christopher Stern is a Managing Director and Partner in L.E.K.’s Life Sciences practice and is based in the Boston office. He works with clients across the life sciences industry, from large pharmaceutical companies to emerging biotechnology firms, helping them navigate complex challenges and develop strategies for asset, therapeutic area, and corporate growth. His expertise spans therapeutic areas with rapidly evolving standards of care, with extensive experience in ophthalmology, central nervous system (CNS) disorders, and cardiometabolic disease.

Chris joined L.E.K. in 2013 as a Life Sciences Specialist and has since advised clients on critical strategic initiatives. From 2021 to 2023, he worked at UPMC Enterprises, the innovation and investment arm of UPMC. While there, he served as founding Chief Business Officer for Avista Therapeutics, a portfolio company focused on developing next-generation gene therapies for blinding diseases.

Chris earned his Ph.D. in Neuroscience from the University of Minnesota, where he studied novel molecular mechanisms of neuronal stress peptides. He completed postdoctoral training in neurology and epilepsy at Stanford University School of Medicine. He also holds a B.S. in Biochemistry, graduating summa cum laude, from Saint Vincent College in Pennsylvania.

### Education

**Undergraduate:** Bachelor of Science in Biochemistry, Saint Vincent College

**Graduate:** Ph.D. in Neuroscience, University of Minnesota

![Christopher Stern](https://www.lek.com/sites/default/files/profile-images/christopher-stern-web.png)

### Christopher's Expertise

#### Industries

[Biotech and Pharmaceuticals](https://www.lek.com/industries/life-sciences-pharma/biotech-pharmaceutical)

[Commercial Due Diligence](https://www.lek.com/industries/private-equity-pe/commercial-due-diligence-cdd)

[Private Equity Consulting](https://www.lek.com/industries/private-equity-pe)

#### Capabilities

[Target Identification](https://www.lek.com/capabilities/mergers-acquisitions/target-identification)

[Due Diligence](https://www.lek.com/capabilities/mergers-acquisitions/due-diligence)

[Strategy](https://www.lek.com/capabilities/strategy)

Read more

### Related Insights

[Executive Insights\\
\\
\\
**Life Sciences & Pharma****Future Outlook for the AOM Market**\\
\\
January 9, 2025](https://www.lek.com/insights/hea/us/ei/future-outlook-aom-market)

First name

Last name

Email

Phone number

My locationUnited StatesCanadaAfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBosnia and HerzegovinaBotswanaBrazilBritish Indian Ocean TerritoryBritish Virgin IslandsBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCape VerdeCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos (Keeling) IslandsColombiaComorosCongoCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzech RepublicCôte d’IvoireDemocratic Republic of the CongoDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHondurasHong Kong S.A.R., ChinaHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacao S.A.R., ChinaMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth KoreaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestinian TerritoryPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussiaRwandaRéunionSaint BarthélemySaint HelenaSaint Kitts and NevisSaint LuciaSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth KoreaSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwazilandSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluU.S. Virgin IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited States Minor Outlying IslandsUruguayUzbekistanVanuatuVaticanVenezuelaViet NamWallis and FutunaWestern SaharaYemenZambiaZimbabwe

Reason for contactingBusiness - I'm exploring hiring L.E.K.Press - I'm a media representative seeking an L.E.K. expert perspectiveCareer - I'm exploring working at L.E.K.Events - I'm looking to invite L.E.K. to participate in an upcoming eventOther

Company

Message

Comments

By clicking “Contact me” I acknowledge and agree to the L.E.K. Consulting [Privacy Notice](https://www.lek.com/lek-consulting-privacy-policy).

×